Special Issue "Vaccines and Passive Immune Strategies in Veterinary Medicine"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 129

Special Issue Editors

Dr. Viviana Parreno
E-Mail Website
Guest Editor
1. INCUINTA, Instituto de Virología e Innovaciones Tecnológicas (IVIT), Instituto Nacional de Tecnología Agro-Pecuaria (INTA)-CONICET, Ciudad Autónoma de Buenos Aires C1033AAE, Argentina
2. Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA
3. Instituto de Biotecnologia, Unahur, Universidad Nacional de Hurlingham, Buenos Aires, Argentina
Interests: virology; vaccine; antiviral and antibody testing in the gnotobiotic pig model for rotavirus and norovirus infection and disease
INCUINTA, Instituto de Virología e Innovaciones Tecnológicas (IVIT), Instituto Nacional de Tecnología Agro-Pecuaria (INTA)-CONICET, Ciudad Autónoma de Buenos Aires C1033AAE, Argentina
Interests: diagnostic kits for veterinary and human medicine; veterinary vaccines; chicken IgY product; llama-derived nanobodies; viral diseases

Special Issue Information

Dear Colleagues,

Infectious diseases in animals, including food animals (bovine, porcine, chicken), sport animals such as Thoroughbred horses, and companion animals such as cats and dogs, have a major impact on livestock productivity, as well as animal health and welfare. In addition, there is a very high risk of interspecies transmission (from both domestic and wild animals to humans and vice versa) as we can remember from the recent COVID-19 pandemic. Nowadays, researchers working in the development of veterinary vaccines have access to a great variety of new biotechnological options (programed attenuation, targeted subunit-, vectored-, mRNA-, and DNA-vaccines) making possible the creation of vaccines that have been needed for a long time. In addition, new immunological discoveries have also helped to improve the design of passive immune therapies based on homologous and heterologous, polyclonal, and monoclonal immunoglobulins and their derivates, such as chicken IgY, equine Fab, single chain, and llama/shark-derived nanobodies. These technologies have offered very promising results to complement or preplace vaccination, especially for mucosal diseases. Additionally, the emergence of bacteria with resistance to common antibiotics raises the need to replace the use of antibiotics in livestock production with vaccines and other immunological treatments instead, following the One Health concept. Within this scenario, we are pleased to invite the research community to contribute with a review or a main paper to this Special Issue entitled “Vaccines and Passive Immune Strategies in Veterinary Medicine”. The aim of the issue will be to summarize the results and performances of the latest vaccines and passive immune therapies that are under development for animal diseases. We also invite data regarding the performance, stability and efficacy of products that have already been launched on the veterinary market. We also encourage authors to submit for publication their results from research teams working in the development of animals’ models for vaccine potency testing.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following topics:

  • Targeted subunit and VLP veterinary vaccines;
  • mRNA and DNA vaccines for veterinary use;
  • IgY therapies for animal diseases;
  • Llama-derived nanobodies against animal diseases;
  • Equine Fab antiserum to prevent and treat animal diseases. 

We look forward to receiving your contributions.

Dr. Viviana Parreno
Dr. Marina Bok
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • veterinary vaccine
  • passive immune therapy
  • IgY
  • Fab
  • VHH
  • nanobody
  • VLP

Published Papers

This special issue is now open for submission.
Back to TopTop